Skip to main content


Letrozol is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.

60 tablets, each tablet contains 2,5 mg Letrozole
hologram with serial NO and verification code